NASDAQ: LYRA
Lyra Therapeutics Inc Stock Ownership - Who owns Lyra Therapeutics?

Insider buying vs selling

Have Lyra Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when LYRA insiders and whales buy or sell their stock.

LYRA Shareholders

What type of owners hold Lyra Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC19.36%12,757,562$1.10MInstitution
Blackrock Inc4.72%3,109,798$267.44kInstitution
Edward T. Anderson4.01%2,640,228$227.06kInsider
Perceptive Advisors LLC3.91%2,576,892$221.61kInsider
Nbvm GP LLC3.83%2,521,745$216.87kInsider
Samsara Biocapital LLC2.98%1,965,689$169.05kInstitution
Vanguard Group Inc2.71%1,787,422$153.72kInstitution
Maria Palasis1.67%1,100,000$94.60kInsider
Ikarian Capital LLC1.61%1,058,148$91.00kInstitution
Geode Capital Management LLC1.34%885,966$76.19kInstitution

1 of 3

LYRA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LYRA40.81%15.59%
LIPO0.53%69.70%Net Buying
QNRX7.51%7.08%Net Buying
BCLI1.19%98.81%Net Buying
GNPX1.21%21.13%Net SellingNet Selling

Lyra Therapeutics Stock Ownership FAQ

Who owns Lyra Therapeutics?

Lyra Therapeutics (NASDAQ: LYRA) is owned by 40.81% institutional shareholders, 15.59% Lyra Therapeutics insiders, and 43.60% retail investors. Edward T. Anderson is the largest individual Lyra Therapeutics shareholder, owning 2.64M shares representing 4.01% of the company. Edward T. Anderson's Lyra Therapeutics shares are currently valued at $229.70k.

If you're new to stock investing, here's how to buy Lyra Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.